has tirzepatide been fda approved confirms shortage is still over, gives compounders a grace period New Blockbuster Type 2 Medication

It is important to note that these metabolic adaptations are generally physiological responses to weight loss rather than pathological changes

Chinnadurai R, Ritchie J, Green D, Kalra PA

doi:10.1038/laban0512-129 pmid:22517091 Bondolfi L, Ermini F, Long JM, Ingram DK, Jucker M (2004) Impact of age and caloric restriction on neurogenesis in the dentate gyrus of C57BL/6 mice

Patients lose 30-35% of body weight (higher than with tirzepatide), no longer need any GLP-1 drugs, metformin or other anti-diabetes medications, and the costs become lifelong

Countries like China, India, Japan and South Korea have a huge population suffering from diabetes